
About Modern Synthesis
Modern Synthesis is a Retail company based in London (United Kingdom) founded in 2019 by Ben Reeve and Jen Keane. Biomaterials are developed via microbial fermentation for diverse applications. It operates in the Retail and Chemicals & Materials sectors. Modern Synthesis has raised $9.6 million across 2 funding rounds from investors including ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans. Its chief executive, as recorded, is Jen Keane. Its Indian entity Ironsource India Private Limited reported revenue of βΉ21.75 Cr. Modern Synthesis offers products and services including Nanocellulose and Microcraft. Its focus areas include Consumer, Fashion Tech, Innovative Materials and Sustainable Fabrics. Its competitors include Heartbeat, WIDDOP and First Editions.
Company details
Modern Synthesis was founded in 2019 in London, United Kingdom, within the biotechnology sector. Microbes are engineered to convert agricultural sugars into nanocellulose, producing customizable materials that replace animal- and fossil-fuel-derived options. Biology, material science, engineering, and design are integrated in the process to create circular solutions. Collaborations with companies are pursued to tackle issues such as greenhouse gas emissions, waste, land use, plastic pollution, and animal welfare.
- Headquarters London, United Kingdom
- Founders Ben Reeve, Jen Keane
- SectorsRetailChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Website modernsynthesis.com
- Social LinkedIn Instagram
- Legal Name Modern Synthesis Limited
- Date of Incorporation 04 Jul, 2019
- Jurisdiction LONDON, ENGLAND
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Total Equity Funding$9.6M (USD)
in 2 rounds
- Latest Funding Round$5.5M (USD), Seed
Feb 2025
- InvestorsARTESIAN PARTNERS
& 12 more
Associated legal entities of Modern Synthesis
Modern Synthesis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Products & Services of Modern Synthesis
Modern Synthesis offers a comprehensive portfolio of products and services, including Nanocellulose and Microcraft.
Sustainable fiber from microbes replacing plastics in textiles
Redefines craft using nanomaterials for eco-friendly applications
Funding Insights of Modern Synthesis
Modern Synthesis has successfully raised a total of $9.6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5.5 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.6M
- Total Rounds 2
- Last Round Seed β $5.5M
- First Round $4.1M
(Jun 2022)
- Investors Count 13
All 2 funding rounds of Modern Synthesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $5.5M | Seed | β | Extantia | |
| Jun 2022 | $4.1M | Seed | β | β |
13 investors in total: 12 institutional and 1 angel.
Investors in Modern Synthesis
Modern Synthesis has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Extantia is focused on investing in climate technology pioneers. | extantia.com | |||
Private equity firm investing in multiple sectors | collabfund.com | New York, United States | ||
Single family office focused on multiple sectors | 2021 | artesian.com | Denver, United States | |
Venture capital fund focused on ag-tech and food-tech sectors | agfunder.com | San Francisco, United States | ||
Investments are made in early-stage tech companies by Acequia Capital. | acecap.com | Seattle, United States | ||
Early-stage investments across multiple sectors are conducted by this firm. | possible.ventures | Munich, Germany | ||
VC firm investing in tech startups across US and China | imo.vc | San Mateo, United States | ||
Investments in tech startups are made by Taihill Venture. | taihill.vc | Cambridge, United States | ||
Venture capital is invested in climate tech startups and entrepreneurs. | climatecapital.co | San Francisco, United States | ||
Microbe-based drugs are manufactured by Petri Bio in biotechnology. | 2019 | petribio.com | Los Angeles, United States |
Investor details for Modern Synthesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ironsource India Private Limited (Modern Synthesis)
Ironsource India Private Limited is the primary company behind Modern Synthesis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
People of Modern Synthesis
10 people are tracked at Modern Synthesis (4 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Ben Reeve | Co-Founder | Leadership |
Jen Keane | Co-Founder & CEO | Leadership |
Neil Buckney | Head of Engineering | Leadership |
Sarah West Young | Head of Growth | Leadership |
Isaac Hiorns | Senior Materials And Manufacturing Engineer | Team |
Ioannis Zampetakis | Senior Scientist Group Lead | Team |
Louis Graham | People And Culture Manager | Team |
Christopher Chew | Portfolio | Team |
Alice Potts | Senior Innovation Concept Designer | Team |
Teodóra Gál | Biomaterials Chemist Project Lead | Team |
Complete people profiles for Modern Synthesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Modern Synthesis
Figures of Ironsource India Private Limited, the primary company behind Modern Synthesis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for Modern Synthesis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Modern Synthesis
3 dated milestones of Modern Synthesis across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Modern Synthesis is founded.
- Funding First funding round of $4.1M.
- Funding Latest funding round, Seed, of $5.5M.
Competitors of Modern Synthesis
Modern Synthesis has 3 listed competitors in our database. They include Heartbeat, WIDDOP and First Editions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heartbeatuk.com | 1946 | Redditch, United Kingdom | 98 | Contract manufacturing of furniture and shop design products is provided. | ||
| widdop.co.uk | 1883 | Oldham, United Kingdom | Home decor products are manufactured on contract by Widdop. | |||
| firsteditionsltd.com | 1994 | Birmingham, United Kingdom | 11 | Bottles are manufactured on a contract basis for various clients. |
Detailed competitors of Modern Synthesis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Modern Synthesis
Complete news archive for Modern Synthesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modern Synthesis
Modern Synthesis was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Modern Synthesis is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jen Keane is the CEO of Modern Synthesis, as recorded in our data. They have also founded this company.
Modern Synthesis is a funded company, having raised a total of $9.6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.1M, raised on Jun 2022.
The primary company behind Modern Synthesis, Ironsource India Private Limited, reported revenue of βΉ21.75 Cr for FY 2025, up 206% year on year.
Modern Synthesis was founded in 2019 in London, United Kingdom, within the biotechnology sector. Microbes are engineered to convert agricultural sugars into nanocellulose, producing customizable materials that replace animal- and fossil-fuel-derived options. Biology, material science, engineering, and design are integrated in the process to create circular solutions. Collaborations with companies are pursued to tackle issues such as greenhouse gas emissions, waste, land use, plastic pollution, and animal welfare.
Modern Synthesis's top competitors include Heartbeat, WIDDOP and First Editions.
Modern Synthesis offers Nanocellulose and Microcraft.
Modern Synthesis has 13 investors. Key investors include ARTESIAN PARTNERS, Petri Bio, Parley for the Oceans, Extantia, and Collab Fund.
Modern Synthesis operates through Ironsource India Private Limited.
The legal entities of Modern Synthesis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.
